Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) serves as a notification to the Securities and Exchange Commission regarding the submission of its Annual Report on Form 20-F for the fiscal year ended 31 December 2013. The filing was made on 28 February 2014 and signed on 3 March 2014. The document confirms that audited financial statements for the 2013 fiscal year are included in the referenced Form 20-F.
Key Financial Metrics
The provided text does not contain specific financial data. It acts solely as a cover announcement directing investors to the full Annual Report on Form 20-F for details on revenue, profit, cash flow, margins, debt, and liquidity. No numerical values for these metrics are present in this filing.
Material Changes
The filing text does not provide specific comparative financial data or detail material changes versus the prior period. It references the availability of the full 2013 Annual Report for comprehensive financial analysis.
Guidance, Outlook, and Risks
- Forward-Looking Statements: GSK includes a cautionary statement noting that any forward-looking statements or projections are subject to risks and uncertainties that may cause actual results to differ materially.
- Risk Factors: The filing directs investors to Item 3.D "Risk factors" within the 2013 Annual Report on Form 20-F for a detailed description of potential risks.
- Shareholder Information: Shareholders may receive email notifications of financial reports via www.shareview.co.uk. Hard copies of the Annual Report and audited statements are available upon request through registrars (Equiniti), the ADR depositary (BNY Mellon), or the GSK Response Center.
Investor Verification Checklist
- Verify the full audited financial statements in the Annual Report on Form 20-F filed on 28 February 2014.
- Review Item 3.D "Risk factors" in the Form 20-F for specific operational and market risks.
- Confirm the availability of hard copy reports through the listed contact channels (Equiniti, BNY Mellon, or GSK Response Center).
- Note that this Form 6-K contains no standalone financial figures and relies entirely on the referenced Form 20-F for data.